Literature DB >> 15158451

Phosphorylation of the mitochondrial protein Sab by stress-activated protein kinase 3.

Naomi W Court1, Ivana Kuo, Oonagh Quigley, Marie A Bogoyevitch.   

Abstract

Mitogen-activated protein kinases (MAPKs) transduce extracellular signals into responses such as growth, differentiation, and death through their phosphorylation of specific substrate proteins. Early studies showed the consensus sequence (Pro/X)-X-(Ser/Thr)-Pro to be phosphorylated by MAPKs. Docking domains such as the "kinase interaction motif" (KIM) also appear to be crucial for efficient substrate phosphorylation. Here, we show that stress-activated protein kinase-3 (SAPK3), a p38 MAPK subfamily member, localizes to the mitochondria. Activated SAPK3 phosphorylates the mitochondrial protein Sab, an in vitro substrate of c-Jun N-terminal kinase (JNK). Sab phosphorylation by SAPK3 was dependent on the most N-terminal KIM (KIM1) of Sab and occurred primarily on Ser321. This appeared to be dependent on the position of Ser321 within Sab and the sequence immediately surrounding it. Our results suggest that SAPK3 and JNK may share a common target at the mitochondria and provide new insights into the substrate recognition by SAPK3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158451     DOI: 10.1016/j.bbrc.2004.04.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

Review 2.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

3.  p38γ activity is required for maintenance of slow skeletal muscle size.

Authors:  William H Foster; James G Tidball; Yibin Wang
Journal:  Muscle Nerve       Date:  2012-02       Impact factor: 3.217

4.  c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice.

Authors:  Sanda Win; Tin Aung Than; Derick Han; Lydia M Petrovic; Neil Kaplowitz
Journal:  J Biol Chem       Date:  2011-08-15       Impact factor: 5.157

5.  Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction.

Authors:  Yuwei Jiang; Jiaoya Xu; Ping Huang; Lili Yang; Yang Liu; Yiping Li; Jue Wang; Haiyan Song; Peiyong Zheng
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

6.  c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src.

Authors:  Sanda Win; Tin Aung Than; Robert Win Maw Min; Mariam Aghajan; Neil Kaplowitz
Journal:  Hepatology       Date:  2016-03-15       Impact factor: 17.425

7.  New Insights into the p38γ and p38δ MAPK Pathways.

Authors:  Ana Risco; Ana Cuenda
Journal:  J Signal Transduct       Date:  2011-11-30

8.  Protein kinases associated with the yeast phosphoproteome.

Authors:  Ross I Brinkworth; Alan L Munn; Bostjan Kobe
Journal:  BMC Bioinformatics       Date:  2006-01-31       Impact factor: 3.169

9.  Predikin and PredikinDB: a computational framework for the prediction of protein kinase peptide specificity and an associated database of phosphorylation sites.

Authors:  Neil F W Saunders; Ross I Brinkworth; Thomas Huber; Bruce E Kemp; Bostjan Kobe
Journal:  BMC Bioinformatics       Date:  2008-05-26       Impact factor: 3.169

10.  De novo transcriptome assembly and comparative analysis of differentially expressed genes in Prunus dulcis Mill. in response to freezing stress.

Authors:  Sadegh Mousavi; Arghavan Alisoltani; Behrouz Shiran; Hossein Fallahi; Esameil Ebrahimie; Ali Imani; Saadollah Houshmand
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.